TP53 mutations and S-phase fraction but not DNA-ploidy are independent prognostic indicators in laryngeal squamous cell carcinoma

Journal of Cellular Physiology

Volumn 206, Issue 1, 2006, Pages 181-188

  Russo, Antonio ^a,d   Corsale, Simona ^a   Agnese, Valentina ^a   Macaluso, Marcella ^a,b   Cascio, Sandra ^a,b   Bruno, Loredana ^a   Surmacz, Eva ^b   Dardanoni, Gabriella ^c   Valerio, Maria Rosaria ^a   Vieni, Salvatore ^a   Restivo, Salvatore ^a   Fulfaro, Fabio ^a   Tomasino, Rosa Maria ^a   Gebbia, Nicola ^a   Bazan, Viviana ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b Temple University   (United States)

^c Epidemiological Observatory Center of Sicilian Region   (Italy)

^d NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADVANCED CANCER; ARTICLE; CELL CYCLE S PHASE; DNA CONTENT; EXON; FLOW CYTOMETRY; FOLLOW UP; GENE; GENE MUTATION; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LARYNX CARCINOMA; MULTIVARIATE ANALYSIS; PLOIDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SINGLE STRAND CONFORMATION POLYMORPHISM; SQUAMOUS CELL CARCINOMA; TP53 GENE;

CARCINOMA, SQUAMOUS CELL; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; GENES, RAS; HUMANS; LARYNGEAL NEOPLASMS; MUTATION; PLOIDIES; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROGNOSIS; S PHASE; SURVIVAL RATE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 28444461468     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20447     Document Type: Article

References (52)

1. Aisner J, Sorensen SB, Overgaard J. 2001. TP53 mutation is related to poor prognosis after radiotherapy, but not surgery, in squamous cell carcinoma of the head and neck. Radiother Oncol 59(29):179-185.
2. Anwar K, Nakakuki K, Imai H, Naiki H, Inuzuka M. 1993a. Over-expression of p53 protein in human laryngeal carcinoma. Int J Cancer 53(6):952-956.
3. Anwar K, Nakakuki K, Naiki H, Inuzuka M. 1993b. Ras gene mutations and HPV infection are common in human laryngeal carcinoma. Int J Cancer 53(1): 22-28.
4. Bazan V, Zanna I, Migliavacca M, Sanz-Casla MT, Maestro ML, Corsale S, Macaluso M, Dardanoni G, Restivo S, Quintela PL, Bernaldez R, Salerno S, Morello V, Tomasino RM, Gebbia N, Russo A. 2002a. Prognostic significance of p16INK4a alterations and 9p21 loss of heterozygosity in locally advanced laryngeal squamous cell carcinoma. J Cell Physiol 192(3):286-293.
5. Bazan V, Migliavacca M, Tubiolo C, Macaluso M, Zanna I, Corsale S, Amato A, Calo V, Dardanoni G, Morello V, La Farina M, Albanese I, Tomasino RM, Gebbia N, Russo A. 2002b. Have p53 gene mutations and protein expression a different biological significance in colorectal cancer? J Cell Physiol 191:237-246.
6. Bazan V, La Rocca G, Corsale S, Agnese V, Macaluso M, Migliavacca M, Gregorio V, Cascio S, Sisto PS, Di Fede G, Buscemi M, Fiorentino E, Passantino R, Morello V, Tomasino RM, Russo A. 2005. Laser pressure catapulting (LPC): Optimization LPC-system and genotyping of colorectal carcinomas. J Cell Physiol 202(2):503-509.
7. Boag G, Lee CS, Charalambous D, Rode J. 1993. p53 expression in laryngeal carcinoma. Pathology 25(4):394-397.
8. Boyle JO, Hakim J, Koch W, van der Riet P, Hruban RH, Roa RA, Correo R, Eby YJ, Ruppert JM, Sidransky D. 1993. The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res 53(19):4477-4480.
9. Brachman DG, Graves D, Yokes E, Beckett M, Haraf D, Montag A, Dunphy E, Mick R, Yandell D, Weichselbaum RR. 1992. Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer. Cancer Res 52(17):4832-4836.
10. Califano J, van der Riet P, Westra W, Nawroz H, Clayman G, Piantadosi S, Corio R, Lee D, Greenberg B, Koch W, Sidransky D. 1996. Genetic progression model for head and neck cancer: Implications for field cancerization. Cancer Res 56(11):2488-2492.
11. Califano J, Westra WH, Meininger G, Corio R, Koch WM, Sidransky D. 2000. Genetic progression and clonal relationship of recurrent premalignant head and neck lesions. Clin Cancer Res 6(2):347-352.
12. Chang F, Syrjanen S, Kurvinen K, Syrjanen K. 1993. The p53 tumor suppressor gene as a common cellular target in human carcinogenesis. Am J Gastroenterol 88(2):174-186.
13. Cho Y, Gorina S, Jeffrey PD, Pavletich NP. 1994. Crystal structure of a p53 tumor suppressor-DNA complex: Understanding tumorigenic mutations. Science 265(5170):346-355.
14. Chomchai JS, Du W, Sarkar FH, Li YW, Jacobs JR, Ensley JF, Sakr W, Yoo GH. 1999. Prognostic significance of p53 gene mutations in laryngeal cancer. Laryngoscope 109(3):455-459.
15. Chung KY, Mukhopadhyay T, Kim J, Casson A, Ro JY, Goepfert H, Hong WK, Roth JA. 1993. Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract. Cancer Res 53(7):1676-1683.
16. Cox D. 1972. Regression models and life tables. J Am Stat Assoc 34:187-220.
17. Dolcetti R, Doglioni C, Maestro R, Gasparotto D, Barman L, Pastore A, Romanelli M, Baiocchi M. 1992. p53 over-expression is an early event in the development of human squamous-cell carcinoma of the larynx: Genetic and prognostic implications. Int J Cancer 52(2):178-182.
18. Dowell SP, Hall PA. 1995. The p53 tumour suppressor gene and tumour prognosis: Is there a relationship? J Pathol 177(3):221-224.
19. Field JK, Pavelic ZP, Spandidos DA, Stambrook PJ, Jones AS, Gluckman JL. 1993. The role of the p53 tumor suppressor gene in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 119(10):1118-1122.
20. Fracchiolla NS, Pignataro L, Capaccio P, Trecca D, Boletini A, Ottaviani A, Polli E, Maiolo AT, Neri A. 1995. Multiple genetic lesions in laryngeal squamous cell carcinomas. Cancer 75(6):1292-1301.
21. Goldsmith MM, Pillsbury HC. 1991. Pathologic and cytometric indicators of biologic behaviour in laryngeal cancer. In: Silver CE, editor. Laryngeal cancer. New York: Thieme Medical Publisher, pp 27-32.
22. Golusinski W, Olofsson J, Szmeja Z, Szyfter K, Szyfter W, Biczysko W, Hemminki K. 1997. Alteration of p53 gene structure and function in laryngeal squamous cell cancer. Eur Arch Otorhinolaryngol 254 Suppl 1:S133-S137.
23. Hirvikoski P, Kumpulainen E, Virtaniemi J, Johansson R, Haapasalo H, Marin S, Halonen P, Heiin H, Raitiola H, Pukander J, Kellokumpu-Lehtinen P, Kosma VM. 1997. p53 expression and cell proliferation as prognostic factors in laryngeal squamous cell carcinoma. J Clin Oncol 15(9):3111-3120.
24. Iniesta P, Vega FJ, Caldes T, Massa M, de Juan C, Cerdan FJ, Sanchez A, Lopez JA, Torres AJ, Balibrea JL, Benito M. 1998. p53 exon 7 mutations as a predictor of poor prognosis in patients with colorectal cancer. Cancer Lett 130(1-2):153-160.
25. Jackel MC, Sellmann L, Youssef S, Dorudian MA, Fuzesi L. 2001. Prognostic significance of expression of p53, bcl-2 and bax in squamous epithelial carcinoma of the larynx-a multivariate analysis. HNO 49(3):204-211.
26. Jin YT, Kayser S, Kemp BL, Ordonez NG, Tucker SL, Clayman GL, Goepfert H, Luna MA, Batsakis JG, El-Naggar AK. 1998. The prognostic significance of the biomarkers p21WAF1/CIP1, p53, and bcl-2 in laryngeal squamous cell carcinoma. Cancer 82(11):2159-2165.
27. Kiaris H, Spandidos DA. 1995. Analysis of H-ras, K-ras and N-ras genes expression, mutation and amplification in laryngeal tumours. Int J Oncol 7: 75-80.
28. Kiaris H, Spandidos DA, Jones AS, Vaughan ED, Field JK. 1995. Mutations, expression and genomic instability of the H-ras proto-oncogene in squamous cell carcinomas of the head and neck. Br J Cancer 72(1):123-128.
29. Ko LJ, Prives C. 1996. p53: Puzzle and paradigm. Genes Dev 10(9):1054-1072.
30. La Farina M, Maturi N, Stira S, Russo A, Bazan V, Albanese I. 1998. Direct identification of each specific mutation in codon 12 and 13 of ci-ki-ras2 by SSCP analysis. Biochem Biophys Res Commun 246(3):813-815.
31. Lane DP. 1999. Exploiting the p53 pathway for cancer diagnosis and therapy. Br J Cancer 80 Suppl 1:1-15.
32. Levine AJ. 1997. p53, the cellular gatekeeper for growth and division. Cell 88(3): 323-331
33. Levine AJ, Perry ME, Chang A, Silver A, Dittmer D, Wu M, Welsh D. 1994. The 1993 Walter Hubert Lecture: The role of the p53 tumour-suppressor gene in tumorigenesis. Br J Cancer 69(3):409-416.
34. Li Y. 1995. Relationship between mutation of p53 gene and malignant level of squamous carcinoma in the larynx. Zhonghua Er Bi Yan Hou Ke Za Zhi 30(2):101-104.
35. Maestro R, Dolcetti R, Gasparotto D, Doglioni C, Pelucchi S, Barzan L, Grandi E, Boiocchi M. 1992. High frequency of p53 gene alterations associated with protein overexpression in human squamous cell carcinoma of the larynx. Oncogene 7(6):1159-1166.
36. McDonald JS, Jones H, Pavelic ZP, Pavelic LJ, Stambrook PJ, Gluckman JL. 1994. Immunohistochemical detection of the H-ras, K-ras, and N-ras oncogenes in squamous cell carcinoma of the head and neck. J Oral Pathol Med 23(8):342-346.
37. Merkel DE, McGuire WL. 1990. Ploidy, proliferative activity and prognosis. DNA flow cytometry of solid tumors. Cancer 65(5):1194-1205.
38. Nadal A, Cardesa A. 2003. Molecular biology of laryngeal squamous cell carcinoma. Virchows Arch 442(1):1-7.
39. Parkin DM, Pisani P, Ferlay J. 1993. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 54(4):594-606.
40. Prives C, Hall PA. 1999. The p53 pathway. J Pathol 187(1):112-126.
41. Rizos E, Sourvinos G, Arvanitis DA, Velegrakis G, Spandidos DA. 1999. Low incidence of H-, K- and N-ras oncogene mutations in cytological specimens of laryngeal tumours. Oral Oncol 35(6):561-563.
42. Ronchetti D, Neglia CB, Cesana BM, Carboni N, Neri A, Pruneti G, Pignataro L. 2004. Association between p53 gene mutations and tobacco and alcohol exposure in laryngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 130(3):303-306.
43. Ross DW. 1993. Clinical usefulness of DNA ploidy and cell cycle studies. Arch Pathol Lab Med 117(11):1077.
44. Russo A, Bazan V, Morello V, Tralongo V, Nagar C, Nuara RB, Dardanoni G, Bazan P, Tomasino RM. 1994. Vimentin expression, proliferating cell nuclear antigen and flow cytometric factors. Prognostic role in breast cancer. Anal Quant Cytol Histol 16(5):365-374.
45. Russo A, Bazan V, Gebbia N, Pizzolanti G, Tumminello FM, Dardanoni G, Ingria F, Restivo S, Tomasino RM, Leto G. 1995. Flow cytometric DNA analysis and lysosomal cathepsins B and L in locally advanced laryngeal cancer. Relationship with clinicopathologic parameters and prognostic significance. Cancer 76(10):1757-1764.
46. Russo A, Migliavacca M, Zanna I, Valerio MR, Latteri MA, Grassi N, Pantuso G, Salerno S, Dardanoni G, Albanese I, La Farina M, Tomasino RM, Gebbia N, Bazan V. 2002. p53 mutations in L3-loop zinc-binding domain, DNA-ploidy, and S phase fraction are independent prognostic indicators in colorectal cancer: A prospective study with a five-year follow-up. Cancer Epidemiol Biomarkers Prev 11(11):1322-1331.
47. Sakai E, Tsuchida N. 1992. Most human squamous cell carcinomas in the oral cavity contain mutated p53 tumor-suppressor genes. Oncogene 7(5):927-933.
48. Sarkar FH, Sakr WA, Li YW, Jacobs J, Crissman JD. 1996. Tumor suppressor p53 gene mutation in squamous cell carcinoma of the larynx. Diagn Mol Pathol 5(3):201-205.
49. Somasundaram K. 2000. Tumor suppressor p53: Regulation and function. Front Biosci 5:D424-D437.
50. Soussi T, Legros Y, Lubin R, Dry K, Schlichtholz B. 1994. Multifactorial analysis of p53 alteration in human cancer: A review. Int J Cancer 57(1):1-9.
51. Tomasino RM, Daniele E, Bazan V, Morello V, Tralongo V, Nuara R, Nagar C, Salvato M, Ingria F, Restivo S, Dardanoni G, Vecchione A, Russo A. 1995. Prognostic significance of cell kinetics in laryngeal squamous cell carcinoma: Clinicopathological associations. Cancer Res 55(24):6103-6108.
52. Tomasino RM, Bazan V, Daniele E, Nuara R, Morello V, Tralongo V, Leto G, Russo A. 1996. Biological characterization of laryngeal squamous-cell carcinoma. Anticancer Res 16(4B):2257-2267.